References
Self A, Cavallaro A, Collins SL. Placenta accreta spectrum: imaging and diagnosis. Obstet Gynecol. 2025;27:15-28. doi:10.1111/tog.12956.
Heller DS. Placenta accreta and percreta. Surg Pathol Clin. 2013;6(1):181-197. doi:10.1016/j.path.2012.10.003.
Lee S, Kim SC. Clinical insights into placenta accreta spectrum: a comprehensive review. Obstet Gynecol Sci. 2026 Jan;69(1):1-15. doi: 10.5468/ogs.25231.
Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:84-91. doi:10.1016/j.bpobgyn.2020.07.011.
Eleje GU, Ikechebelu JI, Chidozie CP, Malachy DE, Egwuatu EC, Umeoranefo IC, et al. Prevalence, emerging aetiologies, and contemporary predictors of primary postpartum haemorrhage in a tertiary-level obstetric population in Nnewi, Nigeria: a pilot study. Kronika. 2025;25(12):486-516. doi: 10.5281/zenodo.18045578.
Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of ]narrative review articles. Res Integr Peer Rev. 2019 Mar 26;4:5. doi: 10.1186/s41073-019-0064-8.
Wekere FCC, Inimgba NM, Kua PL, Okagua KE, Asikimabo-Ofori S, Ocheche US, et al. Placenta Accreta Spectrum: Prevalence, Trend and Association with Sociodemographic / Obstetric Factors in a Tertiary Health Facility in Niger Delta, Nigeria. Niger Med J. 2023 Feb 24;63(6):467-473.
Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J Med. 2018 Apr 19;378(16):1529-1536. doi: 10.1056/NEJMcp1709324.
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005 May;192(5):1458-61. doi: 10.1016/j.ajog.2004.12.074.
Bailit JL, Grobman WA, Rice MM, Reddy UM, Wapner RJ, Varner MW, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015 Mar;125(3):683-689. doi: 10.1097/AOG.0000000000000680.
Umezurike CC, Nkwocha G. Placenta accreta in Aba, south eastern, Nigeria. Niger J Med. 2007 Jul-Sep;16(3):219-22.
Jauniaux E, Grønbeck L, Bunce C, Langhoff-Roos J, Collins SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019 Nov 12;9(11):e031193. doi: 10.1136/bmjopen-2019-031193.
Brown AD, Hart JM, Modest AM, Hess PE, Abbas AM, Nieto-Calvache AJ, et al. Geographic variation in management of patients with placenta accreta spectrum: An international survey of experts (GPASS). Int J Gynaecol Obstet. 2022 Jul;158(1):129-136. doi: 10.1002/ijgo.13960.
Umeh UA, Eleje GU, Onuh JU, Nwankwo OT, Ezeome IV, Ajah LO, et al. Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval. Obstet Gynecol Int. 2022 Aug 3;2022:8028639. doi: 10.1155/2022/8028639.
Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019 Jul;146(1):20-24. doi: 10.1002/ijgo.12761.
Ishibashi H, Miyamoto M, Iwahashi H, Matsuura H, Kakimoto S, Sakamoto T, et al. Criteria for placenta accreta spectrum in the International Federation of Gynaecology and Obstetrics classification, and topographic invasion area are associated with massive hemorrhage in patients with placenta previa. Acta Obstet Gynecol Scand. 2021 Jun;100(6):1019-1025. doi: 10.1111/aogs.14143.
Shteynman L, Monanian G, Torres G, Sabetta G, Li DM, Jin Z, et al. Pathophysiology and Management of Placenta Accreta Spectrum. J Dev Biol. 2025 Dec 10;13(4):45. doi: 10.3390/jdb13040045.
Muter J, Kong CS, Brosens JJ. The Role of Decidual Subpopulations in Implantation, Menstruation and Miscarriage. Front Reprod Health. 2021 Dec 23;3:804921. doi: 10.3389/frph.2021.804921.
Cindrova-Davies T, Sferruzzi-Perri AN. Human placental development and function. Semin Cell Dev Biol. 2022;131:66-77. doi:10.1016/j.semcdb.2022.03.039.
Lin Z, Wu S, Jiang Y, Chen Z, Huang X, Wen Z, Yuan Y. Unraveling the molecular mechanisms driving enhanced invasion capability of extravillous trophoblast cells: a comprehensive review. J Assist Reprod Genet. 2024 Mar;41(3):591-608. doi: 10.1007/s10815-024-03036-6.
Lee C, Kim MJ, Kumar A, Lee HW, Yang Y, Kim Y. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
Umeononihu OS, Eleje GU, Edeh C, Anikwe CC, Oguaka VN. Successful pregnancy with placenta accreta spectrum and uterine atony following conservative ovarian cancer treatment: a case report. J Cancer Res Rev Rep. 2025;234:2–4. doi:10.47363/JCRR/2025(7).
Imafuku H, Tanimura K, Shi Y, Uchida A, Deguchi M, Terai Y. Clinical factors associated with a placenta accreta spectrum. Placenta. 2021 Sep 1;112:180-184. doi: 10.1016/j.placenta.2021.08.001.
Liu X, Wang Y, Wu Y, Zeng J, Yuan X, Tong C, et al. What we know about placenta accreta spectrum (PAS). Eur J Obstet Gynecol Reprod Biol. 2021 Apr;259:81-89. doi: 10.1016/j.ejogrb.2021.02.001.
di Pasquo E, Ghi T, Calì G, D'Antonio F, Fratelli N, Forlani F, et al. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta. Ultrasound Obstet Gynecol. 2020 Apr;55(4):460-466. doi: 10.1002/uog.21866.
Hussein AM, Thabet MM, Elbarmelgy RM, Elbarmelgy RA, Jauniaux E. Evaluation of the role of the rail sign and intracervical lakes in the management of patients with a high probability of placenta accreta spectrum. BMC Pregnancy Childbirth. 2026 Feb 9;26(1):272. doi: 10.1186/s12884-026-08766-2.
Nieto Alvarez I, Madl J, Becker L, Amft O. Patients' Experience to MRI Examinations-A Systematic Qualitative Review With Meta-Synthesis. J Magn Reson Imaging. 2025 Jan;61(1):480-493. doi: 10.1002/jmri.29365.
Pain FA, Dohan A, Grange G, Marcellin L, Uzan-Augui J, Goffinet F, et al. Percreta score to differentiate between placenta accreta and placenta percreta with ultrasound and MR imaging. Acta Obstet Gynecol Scand. 2022 Oct;101(10):1135-1145. doi: 10.1111/aogs.14420.
Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018;218:618.e1‐618.e7.
Romeo V, Verde F, Sarno L, Migliorini S, Petretta M, Mainenti PP, et al. Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings. Radiol Med. 2021 Sep;126(9):1216-1225. doi: 10.1007/s11547-021-01348-6.
Khwankaew N, Pranpanus S, Chotipanvithayakul R. Transvaginal as an adjunct to transabdominal ultrasound improved placenta accreta spectrum disorder diagnostic accuracy in a low-experienced operator. BMC Pregnancy Childbirth. 2025 Oct 1;25(1):999. doi: 10.1186/s12884-025-08091-0.
Mitoma T, Sakata S, Suemori A, Ooba H, Hayata K, Maki J. Intraoperative Transvaginal Ultrasonographic Evaluation for Placenta Accreta Spectrum in Placenta Previa: A Retrospective Observational Study. J Obstet Gynaecol Res. 2026 Jun;52(6):e70353. doi: 10.1111/jog.70353.
Jochum MD, Albrecht KD, Martinez YM, Zhang V, Sarada S, Burnett B, et al. Hematologic markers and machine learning in predicting placenta accreta: A case-control study. Int J Gynaecol Obstet. 2026 Feb 2. doi: 10.1002/ijgo.70782.
Lees CC, Pranpanus S, Dall'Asta A, Aryananda R, Shih JC. Diagnosis of placenta accreta spectrum by the 'rail' and 'tramline' signs: similar names but different techniques and topography. Am J Obstet Gynecol. 2026 Jan 19:S0002-9378(26)00025-6. doi: 10.1016/j.ajog.2026.01.017.
Jauniaux E, D'Antonio F, Bhide A, Prefumo F, Silver RM, Hussein AM, et al. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound Obstet Gynecol. 2023 Apr;61(4):518-525. doi: 10.1002/uog.26155.
Shih JC, Kang J, Tsai SJ, Lee JK, Liu KL, Huang KY. The "rail sign": an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes. Am J Obstet Gynecol. 2021 Sep;225(3):292.e1-292.e17. doi: 10.1016/j.ajog.2021.03.018.
Dall'Asta A, Shah H, Masini G, Paramasivam G, Yazbek J, Bourne T, Lees CC. Evaluation of tramline sign for prenatal diagnosis of abnormally invasive placenta using three-dimensional ultrasound and Crystal Vue rendering technology. Ultrasound Obstet Gynecol. 2018 Sep;52(3):403-404. doi: 10.1002/uog.18975.
Dall'Asta A, Forlani F, Shah H, Paramasivam G, Yazbek J, Bourne T, et al. Evaluation of the Tramline Sign in the Prediction of Placenta Accreta Spectrum and Perioperative Outcomes in Anterior Placenta Previa. Ultraschall Med. 2022 Dec;43(6):e118-e124. English. doi: 10.1055/a-1309-1665.
Kway VB, Castillo Reyther RA, Herrera Alvares MÁ. Leaving Placenta In Situ for Management of Placenta Accreta Spectrum Disorder. Obstet Gynecol. 2025 Oct 1;146(4):e76. doi: 10.1097/AOG.0000000000006038.
Hessami K, Kamepalli S, Lombaard HA, Shamshirsaz AA, Belfort MA, Munoz JL. Conservative management of placenta accreta spectrum is associated with improved surgical outcomes compared to cesarean hysterectomy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2025 May;232(5):432-452.e3. doi: 10.1016/j.ajog.2025.01.030.
Panaitescu AM, Peltecu G, Botezatu R, Iancu G, Gica N. Risk of Subsequent Hysterectomy after Expectant Management in the Treatment of Placenta Accreta Spectrum Disorders. Medicina (Kaunas). 2022 May 19;58(5):678. doi: 10.3390/medicina58050678.
Skubisz MM, Tong S. The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review. ISRN Obstet Gynecol. 2012;2012:637094. doi: 10.5402/2012/637094.
Nieto-Calvache AJ, Palacios-Jaraquemada JM, Aryananda R, Basanta N, Aguilera R, Benavides JP, et al. How to perform the one-step conservative surgery for placenta accreta spectrum move by move. Am J Obstet Gynecol MFM. 2023 Feb;5(2):100802. doi: 10.1016/j.ajogmf.2022.100802.
Kirovakov Z, Yordanov A, Tsoneva E. Placenta accreta spectrum: diagnostic challenges and management strategies. Diagnostics. 2026;16(5):760. doi:10.3390/diagnostics16050760.
Chandraharan E, Rao S, Belli AM, Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012 May;117(2):191-4. doi: 10.1016/j.ijgo.2011.12.005.
Mappa I, Espuelas Malon S, D'Antonio F, Chandraharan E. Effectiveness of the Triple P Procedure and its modifications on reducing the blood loss and peripartum hysterectomy rates in women with Placenta Accreta Spectrum (PAS): a review of published literature. J Matern Fetal Neonatal Med. 2025 Dec;38(1):2452920. doi: 10.1080/14767058.2025.2452920.
Vural M, Pohle M, Rauh M, Kappelmeyer M, Köninger A. Focal excision for placenta percreta based on pathoanatomy: the challenge of neovascularization. Am J Obstet Gynecol. 2026. Available from: https://doi.org/10.1016/j.ajog.2026.05.003.
Parveen S, Zaman N, Ahmed P. Novel treatment approach for recurrent secondary postpartum hemorrhage. Int J Gynaecol Obstet. 2026 Jun 23. doi: 10.1002/ijgo.71168.
Drozdovsky T, Kwok MH, Greco E. Nonconservative vs. Conservative Management of Antenatally Diagnosed Placenta Accreta Spectrum Disorders: A Literature Review of Approaches and Outcomes. Obstet Gynecol Int. 2025 Dec 30;2025:6344708. doi: 10.1155/ogi/6344708.
Arenas GA, Thompson JJ, Pineles BL. Conservative management of placenta accreta spectrum: a modern treatment alternative to cesarean-hysterectomy. Curr Obstet Gynecol Rep. 2024;13:195–206. doi:10.1007/s13669-024-00395-w.
Saaqib S, Naheed M, Iqbal A, Rehman RMAU, Khalid M. Evaluating a novel approach to placenta accreta spectrum management: the modified Triple-P technique with cystoinflation (a randomized controlled trial). Sci Rep. 2025 Jul 16;15(1):25870. doi: 10.1038/s41598-025-07582-6.
Gatta LA, Lee PS, Gilner JB, Weber JM, Adkins L, Salinaro JR, et al, Placental uterine artery embolization followed by delayed hysterectomy for placenta percreta: A case series. Gynecol Oncol Rep. 2021 Jul 16;37:100833. doi: 10.1016/j.gore.2021.100833.
Nyundo M, Umugwaneza N, Bekele A, Chikoya L, Gashegu J, Detry O. Assessment of resource capacity and barriers to effective practice of laparoscopic surgery in training hospitals affiliated with the College of Surgeons of East, Central and Southern Africa (COSECSA). Surg Endosc. 2023;37:5121–5128. doi:10.1007/s00464-023-09985-w.
Tanase Y, Kato MK, Uno M, Ishikawa M, Kato T. Variations in Procedures for Ureterolysis with Sharp Dissection in Minimally Invasive Hysterectomy. Gynecol Minim Invasive Ther. 2022 Aug 5;11(3):171-173. doi: 10.4103/gmit.gmit_129_21.
Wright A, Toh LHW, Chandramohan S, Tan BS, Lee YS, Tay KH, et al. Internal iliac artery balloon occlusion for placenta accreta spectrum disorder: outcomes and factors influencing efficacy. BMC Pregnancy Childbirth. 2026 May 12;26(1):524. doi: 10.1186/s12884-026-09250-7.
Kim SJ, Layden N, Fleming S, Hasan Hİ, Bahabri A, Rylance SL, et al. Prophylactic bilateral internal iliac artery balloon occlusion with immediate sheath removal for placenta accreta spectrum. CVIR Endovasc. 2026 Jan 17;9(1):5. doi: 10.1186/s42155-026-00649-z.
Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020 Feb;222(2):179.e1-179.e9. doi: 10.1016/j.ajog.2019.08.035.
Obiechina NJ, Eleje GU, Ezebialu IU, Okeke CA, Mbamara SU. Emergency peripartum hysterectomy in Nnewi, Nigeria: a 10-year review. Niger J Clin Pract. 2012 Apr-Jun;15(2):168-71. doi: 10.4103/1119-3077.97303.
Jauniaux E, Dimitrova I, Kenyon N, Mhallem M, Kametas NA, Zosmer N, et al. Impact of placenta previa with placenta accreta spectrum disorder on fetal growth. Ultrasound Obstet Gynecol. 2019 Nov;54(5):643-649. doi: 10.1002/uog.20244.
Toussia-Cohen S, Castel E, Friedrich L, Mor N, Ohayon A, Levin G, et al. Neonatal outcomes in pregnancies complicated by placenta accreta- a matched cohort study. Arch Gynecol Obstet. 2024 Jul;310(1):269-275. doi: 10.1007/s00404-023-07353-6.
Nieto-Calvache AJ, Ramasauskaite D, Palacios-Jaraquemada JM, Hussein AM, Jauniaux E, Ubom AEB, et al. Complex cesarean section: Surgical approach to reduce the risks of intraoperative complications and postpartum hemorrhage. Int J Gynaecol Obstet. 2025 Mar;168(3):987-998. doi: 10.1002/ijgo.16094.
Markfeld Erol F, Häußler JA, Medl M, Juhasz-Boess I, Kunze M. Placenta Accreta Spectrum (PAS): Diagnosis, Clinical Presentation, Therapeutic Approaches, and Clinical Outcomes. Medicina (Kaunas). 2024 Jul 20;60(7):1180. doi: 10.3390/medicina60071180.
Rojhani E, Abiad M, Zargarzadeh N, Aghajani F, Lopez MC, Shamshirsaz AA, et al. Placenta Accreta Spectrum After Myomectomy: A Systematic Review and Meta-Analysis Stratified by Surgical Approach. Am J Obstet Gynecol. 2026 Feb 5:S0002-9378(26)00065-7. doi: 10.1016/j.ajog.2026.02.003.
Yang R, Zhang L, Sun L, Wu J, Bi S, Hu M, et al. Risk of Placenta Accreta Spectrum Disorder After Prior Non-Cesarean Delivery Uterine Surgery: A Systematic Review and Meta-analysis. Obstet Gynecol. 2025 Jun 1;145(6):628-638. doi: 10.1097/AOG.0000000000005824.
DI Girolamo R, Buca D, Galliani C, D'Amico A, CALì G, Lucidi A, et al. Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology. Minerva Obstet Gynecol. 2023 Feb;75(1):55-61. doi: 10.23736/S2724-606X.21.04886-7.
Viana Pinto P, Kawka-Paciorkowska K, Morlando M, Huras H, Kołak M, Bertholdt C, et al. Prevalence of fetal anomalies, stillbirth, neonatal morbidity, or mortality in pregnancies complicated by placenta accreta spectrum disorders. Acta Obstet Gynecol Scand. 2025 Apr;104 Suppl 1(Suppl 1):38-44. doi: 10.1111/aogs.14919.
Sugai S, Yamawaki K, Sekizuka T, Haino K, Yoshihara K, Nishijima K. Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023 Dec;5(12):101197. doi: 10.1016/j.ajogmf.2023.101197.
Chen D, Xu J, Tian Y, Ling Q, Peng B. Clinical evaluation of the effect for prophylactic balloon occlusion in pregnancies complicated with placenta accreta spectrum disorder: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2024 Oct;167(1):109-127. doi: 10.1002/ijgo.15704.
Rau AR, Youssefzadeh AC, Matsuzaki S, Mandelbaum RS, Ouzounian JG, Matsuo K. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity. Am J Obstet Gynecol MFM. 2023 May;5(5):100805. doi: 10.1016/j.ajogmf.2022.100805.
Çanga K, Öztürk Ö, Bahadir İB, Elüstü B, Özcan Ü, Yilmaz ZV. Maternal serum thrombospondin-4 levels in placenta accreta spectrum: A case-control study. Int J Gynaecol Obstet. 2026 Jul 5. doi: 10.1002/ijgo.71191.
Murji A, Papalia N, Hobson SR. Planned cesarean hysterectomy for placenta accreta spectrum: safe with the right team. Am J Obstet Gynecol. 2022 Aug;227(2):364-365. doi: 10.1016/j.ajog.2022.03.023.
Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010 Mar;115(3):526-534. doi: 10.1097/AOG.0b013e3181d066d4.
Aryananda RA, Nieto-Calvache AJ, Duvekot JJ, Aditiawarman A, Rijken MJ. Management of unexpected placenta accreta spectrum cases in resource-poor settings. AJOG Glob Rep. 2023 Apr 1;3(2):100191. doi: 10.1016/j.xagr.2023.100191.
Wang M, Ballah D, Wade A, Taylor AG, Rizzuto G, Li B, et al. Uterine Artery Embolization following Cesarean Delivery but prior to Hysterectomy in the Management of Patients with Invasive Placenta. J Vasc Interv Radiol. 2019 May;30(5):687-691. doi: 10.1016/j.jvir.2018.12.007.
El Gelany S, Mosbeh MH, Ibrahim EM, Mohammed M, Khalifa EM, Abdelhakium AK, et al. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study. BMC Pregnancy Childbirth. 2019 Aug 27;19(1):313. doi: 10.1186/s12884-019-2466-5.
Pather S, Strockyj S, Richards A, Campbell N, de Vries B, Ogle R. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol. 2014 Feb;54(1):84-7. doi: 10.1111/ajo.12149.
Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine; Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018 Dec;219(6):B2-B16. doi: 10.1016/j.ajog.2018.09.042.
Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018 Mar;140(3):291-298. doi: 10.1002/ijgo.12410.
Dreux S, Salomon LJ, Muller F, Goffinet F, Oury JF; ABA Study Group; Sentilhes L. Second-trimester maternal serum markers and placenta accreta. Prenat Diagn. 2012 Oct;32(10):1010-2. doi: 10.1002/pd.3932.
Al Naimi A, Wiesmann C, Brueggmann D, Hentrich AE, Deuster E, Hoock SC, et al. The utility of serum markers in the conservative management of placenta accreta spectrum (PAS) by leaving the placenta in situ in women with high-grade PAS. Int J Gynaecol Obstet. 2026 Jun 1. doi: 10.1002/ijgo.71113.
Javinani A, Qaderi S, Hessami K, Shainker SA, Shamshirsaz AA, Fox KA, Mustafa HJ, et al. Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis. Am J Obstet Gynecol. 2024 May;230(5):485-492.e7. doi: 10.1016/j.ajog.2023.10.047.
Vuong ADB, Nguyen XT, Pham XTT, Nguyen PN. Outcomes of subsequent pregnancies following modified one-step conservative uterine surgery (MOSCUS) in the management of placenta accreta spectrum: Two case reports and a narrative review of the literature. Case Rep Womens Health. 2026 Jan 5;49:e00781. doi: 10.1016/j.crwh.2026.e00781.
Nieto-Calvache AJ, Jauniaux E, Fox KA, Maya J, Stefanovic V, Weizsäcker K, et al. Are international guideline recommendations for the management of placenta accreta spectrum applicable in low- and middle-income countries? Int J Gynaecol Obstet. 2024 Sep;166(3):1047-1056. doi: 10.1002/ijgo.15473.
Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018 Mar;140(3):281-290. doi: 10.1002/ijgo.12409.
Mostajeran K, Zurcher KS, Oh C, Garcia-Filion P, Chen S, Goettl C, et al. Selective intraoperative multi-vessel embolization for placenta accreta spectrum: a doubly robust propensity-weighted analysis of a histologically confirmed cohort. Eur J Obstet Gynecol Reprod Biol. 2026;115274. Available from: https://doi.org/10.1016/j.ejogrb.2026.115274.
Liu Z, Chen P, Wang D, Liang Q, Feng Q, Xie L, Liu Y, Sun L, Chen X. Crystal Vue-Estimated placental invasion area as a novel predictor of postpartum hemorrhage risk in placenta accreta spectrum disorders: a retrospective cohort study. BMC Pregnancy Childbirth. 2026 Jan 7;26(1):171. doi: 10.1186/s12884-025-08615-8.
Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers. Dis Markers. 2018 Jul 3;2018:1507674. doi: 10.1155/2018/1507674.
Givens M, Valcheva I, Einerson BD, Rogozińska E, Jauniaux E. Evaluation of maternal serum protein biomarkers in the prenatal evaluation of placenta accreta spectrum: A systematic scoping review. Acta Obstet Gynecol Scand. 2024 Dec;103(12):2335-2347. doi: 10.1111/aogs.14918.
Thiravit S, Ma K, Goldman I, Chanprapaph P, Jha P, Hippe DS, Dighe M. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment With Emphasis on Placental Bulge. AJR Am J Roentgenol. 2021 Dec;217(6):1377-1388. doi: 10.2214/AJR.21.25581.
Pandey AK, Neogi SB, Gautam D, Raushan MR. New realm of placenta accreta spectrum disorder: are we doing enough? Lancet Reg Health Southeast Asia. 2023 Mar 3;14:100173. doi: 10.1016/j.lansea.2023.100173.